| |
|
|
|
Xtalks, online
2023 -8-01
Stakeholders and patients rely on clinical research to ensure that products are quickly and safely brought to market. But successfully navigating the twists and turns of regulations, the US Food and Drug Administration (FDA) guidance and other controls often seems like an impossible task. As quality compliance is all about protecting the patient, it should be a top priority from protocol design through study completion. So how can researchers ensure that all aspects of their trial are high quality, will withstand scrutiny and protect the patient?
Join the Elligo Elite Learning Series presentation, “Quality Compliance Essentials in Clinical Trials: Don’t Be the Next Cautionary Tale,” for an open discussion on reducing risk and increasing certainty in clinical research. Featuring industry leaders, the webinar will explore strategies for decreasing human error, encouraging open communication, maintaining patient privacy and other essential components of compliance. It will also detail the potential quality-compromising hazards and compliance-boosting possibilities of new trial models and technologies. Lastly, the webinar will provide expert insights on site training, infrastructure and oversight so attendees can get reliable results and the utmost in patient safety.
Uncertainty is inherent in clinical research — but risk doesn’t have to be. Register for the webinar to learn more about quality compliance essentials in clinical trials.
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
JulieAnn Blasingim, VP of Compliance and Development, Elligo Health Research® Debra Fontana, Consultant, Polaris Compliance Consultants, Inc. Linda McCarty, Co-Founder, Chief Legal Officer and Privacy Officer, Javara
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2023 -8-01
|
|
|
|
|
|
|
|
Registration:
|
|
Free registration
|
|
|
E-mail:
|
|
ajuurinen@xtalks.com
|
|
|
|
|
|
|
|
|